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Cellular/Molecular
Doc2 Proteins Are Not Required for the Increased
Spontaneous Release Rate in Synaptotagmin-1-Deficient
Neurons
Rocío Díez-Arazola,1 X Marieke Meijer,2 Quentin Bourgeois-Jaarsma,1 X L. Niels Cornelisse,2 X Matthijs Verhage,1,2
and X Alexander J. Groffen2
1Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, Vrije Universiteit
Amsterdam, 1081 HV Amsterdam, The Netherlands, and 2Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam
UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands
Regulated secretion is controlled by Ca 2 sensors with different affinities and subcellular distributions. Inactivation of Syt1
(synaptotagmin-1), the main Ca 2 sensor for synchronous neurotransmission in many neurons, enhances asynchronous and sponta-
neous release rates, suggesting that Syt1 inhibits other sensors with higher Ca 2 affinities and/or lower cooperativities. Such sensors
could include Doc2a and Doc2b, which have been implicated in spontaneous and asynchronous neurotransmitter release and compete
with Syt1 for binding SNARE complexes. Here, we tested this hypothesis using triple-knock-out mice. Inactivation of Doc2a and Doc2b in
Syt1-deficient neurons did not reduce the high spontaneous release rate. Overexpression of Doc2b variants in triple-knock-out neurons
reduced spontaneous release but did not rescue synchronous release. A chimeric construct in which the C2AB domain of Syt1 was
substituted by that of Doc2b did not support synchronous release either. Conversely, the soluble C2AB domain of Syt1 did not affect
spontaneous release. We conclude that the high spontaneous release rate in synaptotagmin-deficient neurons does not involve the
binding of Doc2 proteins to Syt1 binding sites in the SNARE complex. Instead, our results suggest that the C2AB domains of Syt1 and
Doc2b specifically support synchronous and spontaneous release by separate mechanisms. (Both male and female neurons were studied
without sex determination.)
Introduction
Neurotransmitter secretion is induced by action potentials (APs)
which activate voltage-dependent Ca 2 channels and, subse-
quently, Ca 2 sensor proteins in synapses (Südhof, 2013). The
canonical Ca 2 sensor synaptotagmin-1 (Syt1) is anchored in the
synaptic vesicle membrane. It contains two C2 domains which
bind Ca 2 ions in a cooperative manner. Ablation of Syt1 selec-
tively impairs synchronous neurotransmission, whereas asyn-
chronous (slower release triggered by action potentials) and
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Significance Statement
Neurotransmission in the brain is regulated by presynaptic Ca2 concentrations. Multiple Ca2 sensor proteins contribute
to synchronous (Syt1, Syt2), asynchronous (Syt7), and spontaneous (Doc2a/Doc2b) phases of neurotransmitter release.
Genetic ablation of synchronous release was previously shown to affect other release phases, suggesting that multiple
sensors may compete for similar release sites, together encoding stimulus–secretion coupling over a large range of synaptic
Ca2 concentrations. Here, we investigated the extent of functional overlap between Syt1, Doc2a, and Doc2b by reintroduc-
ing wild-type and mutant proteins in triple-knock-out neurons, and conclude that the sensors are highly specialized for
different phases of release.
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spontaneous release (quantal events occurring at resting mem-
brane potential) are unaffected (Littleton et al., 1993; Broadie et
al., 1994; Geppert et al., 1994). In adrenal chromaffin cells, Syt1 is
important for fast-burst exocytosis but not sustained release
(Voets et al., 2001). These findings prompted a “two release com-
ponent” hypothesis (Broadie et al., 1994; Geppert et al., 1994;
Goda and Stevens, 1994), stating that other than the canonical
sensor, a second sensor can occupy release sites and codeter-
mine the Ca 2 dependence of secretion. In Syt1-deficient
neurons, a higher apparent Ca 2 sensitivity and lower coop-
erativity was observed (Xu et al., 2009). Similarly, Syt2 defi-
ciency in the calyx of Held synapse strongly reduces Ca 2
cooperativity (Sun et al., 2007; Kochubey and Schneggen-
burger, 2011), suggesting involvement of additional release
mechanisms, such as alternative sensors with relatively low
cooperativities and high Ca 2 affinities.
Following Syt1, a number of additional Ca 2 sensors were
identified (reviewed by Walter et al., 2011). Syt2 and Syt9 rescue
synchronous release in Syt1-deficient neurons (Xu et al., 2007).
Syt7 and Syt10 do not rescue fast release but contribute to other
Ca 2-secretion coupling mechanisms in neurons and other cell
types (Gustavsson et al., 2008, 2009; Cao et al., 2011). Acute Syt7
knock-down studies in Syt1-null neurons show that Syt7 con-
tributes to asynchronous release (Bacaj et al., 2013). Syt7 en-
hances neurotransmission during high-frequency trains,
thereby compensating for synaptic depression (Turecek et al.,
2017). In chromaffin cells, Syt7 is required for sustained se-
cretion (Schonn et al., 2008). In both neurons and chromaffin
cells, the combined removal of Syt1 and Syt7 leaves a remain-
ing release component. In particular, Syt1-deficient neurons
exhibit an increased spontaneous release rate (Littleton et al.,
1993; Broadie et al., 1994; Xu et al., 2009). Spontaneous release
is unaffected by Syt7 knockdown and inhibited by Syt7 over-
expression (Bacaj et al., 2013), again suggesting that additional
release mechanisms exist.
Spontaneous neurotransmission is mediated by Doc2 pro-
teins, which contain C2AB domains similar to those of Syt1
(Orita et al., 1995; Sakaguchi et al., 1995). The C2AB domains of
Doc2b and Syt1 share several properties: Ca 2-dependent phos-
phatidylserine binding, phosphatidylinositol (4,5)-bisphosphate
and SNARE complex binding, membrane curvature induction,
and fusion of SNARE-containing liposomes (Brose et al., 1992;
Rickman et al., 2004; Martens et al., 2007; Groffen et al., 2010).
Doc2a and Doc2b translocate from the cytosol to the plasma
membrane with high Ca 2 sensitivity (Groffen et al., 2004, 2006).
Doc2b may function as a high-affinity Ca 2 sensor (Groffen et
al., 2006, 2010; Courtney et al., 2018) or by another mechanism
(Pang et al., 2011). The N-terminal domain contains a Munc13-
interacting domain (MID) which mediates plasma membrane
recruitment in response to diacylglycerol (Orita et al., 1997;
Duncan et al., 1999). Doc2 proteins also contribute to asynchro-
nous neurotransmission (Yao et al., 2011a). In chromaffin cells,
Doc2b enhances burst exocytosis and inhibits sustained release
(Friedrich et al., 2008; Pinheiro et al., 2013; Houy et al., 2017).
Doc2 proteins also mediate endocrine processes in pancreatic 
cells (Miyazaki et al., 2009; Ramalingam et al., 2012), adipocytes,
muscle (Fukuda et al., 2009; Ramalingam et al., 2012), and mast
cells (Higashio et al., 2008). Because Syt1 and Doc2 compete for
binding to SNARE complexes (Groffen et al., 2010), Doc2 pro-
teins might be responsible for the high spontaneous release fre-
quency observed in the absence of Syt1.
Here, we generated mice lacking Syt1, Doc2a, and Doc2b and
found that Doc2a/Doc2b do not account for the high spontane-
ous release rate of Syt1-deficient neurons. Our data demonstrate
that the C2AB domains of Syt1 and Doc2b are functionally dis-
tinct, suggesting separate mechanisms for evoked and spontane-
ous neurotransmitter release.
Materials and Methods
Generation of triple-knock-out mice. Animals were housed, bred, and han-
dled in accordance with Dutch and European Union (EU) governmental
guidelines. Protocols were approved by the Vrije Universiteit Animal
Ethics and Welfare Committee (approval number FGA 11-06). Wild-
type C57BL/6 mice were obtained from Charles River Laboratories. Null
alleles for Syt1 (Geppert et al., 1994), Doc2a (Sakaguchi et al., 1999), and
Doc2b (Groffen et al., 2010) were maintained by extensively backcrossing
heterozygous mice with C57BL/6. To produce Syt1 single null mice,
heterozygotes were intercrossed. To produce triple-knock-out (TKO)
mice, a Doc2a / Doc2b / Syt1 / mouse line was first established
and then intercrossed.
Construction of lentiviral overexpression vectors. Expression vectors
encoding wild-type, mutated, or hybrid variants of Syt1 and Doc2b
were constructed as illustrated in Figure 1. NCBI reference sequences
are NP_001028852.2 (rat Syt1), NP_112404.1 (rat Doc2b), and
NP_075226.1 (rat Doc2a).
Autapse culture electrophysiology. Autapse cultures were prepared as
previously described (Groffen et al., 2010). In brief, neurons were disso-
ciated from WT, Syt1 knock-out, and Syt1/Doc2a/Doc2b TKO mouse
hippocampi at embryonic stage E18 and plated on glial microislands.
Whole-cell recordings were performed at room temperature between 14
and 18 d in vitro. The intracellular solution was free of EGTA; it con-
tained the following: 125 mM K -gluconate, 10 mM NaCl, 4.6 mM MgCl2,
4 mM K2-ATP, 15 mM creatine phosphate, 10 U/ml phosphocreatine



























Figure 1. Schematic overview of the constructs investigated in this study, expressed
from lentiviral vectors. The N-terminal domain of rat Syt1 (amino acids 1–141) is abbre-
viated as TMD to emphasize that it includes a transmembrane domain. The N-terminal
domains of rat Doc2a (amino acids 1–92) and Doc2b (amino acids 1–126) are designated
MID to emphasize that they contain a Munc13-binding domain. C2A-C2B domains com-
prise residues 142– 421 (Syt1), 93– 403 (Doc2a), and 127– 412 (Doc2b). Asterisks indi-
cate targeted mutations as specified.
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ing (in mM): 140 NaCl, 2.4 KCl, 4 CaCl2, 4 MgCl2, 10 glucose, and 10
HEPES, pH 7.30, 300 mOsm. Clampfit v10.2 (Molecular Devices) was
used for offline analysis of evoked EPSCs. Data acquisition rate was 10
kHz. Miniature EPSCs were detected using Mini Analysis v6.0.3 (Synap-
tosoft, Inc.) using a threshold amplitude of 8 pA. Each trace was visually
inspected to confirm accuracy of event detection. To calculate synchro-
nous and asynchronous components of the EPSC charge as described, a
homemade routine was written in the MATLAB environment (Math-
Works; for details, see Bourgeois-Jaarsma et al., 2019). For overexpres-
sion of full-length rat Doc2a, Doc2b, and Syt1, cells were infected with
lentiviral vectors encoding Doc2b WT, Syt1 WT, Doc2b DN, Doc2b MID,
Syt1 C2AB, Syt1-Doc2b WT, or Syt1-Doc2b DN on DIV2. Throughout this
paper, DN designates the D218,220N mutation in Doc2b. To control for
effects caused by the lentiviral infection, we used particles encoding GFP
alone. To facilitate a side-by-side comparison between all constructs,
mEPSC frequencies were normalized to that of a control group included
in all experiments. Recordings and analyses were performed while the
identity of experimental groups was unknown to the experimenter.
Network culture and electrophysiology. Hippocampal neurons from
WT, Syt1 knock-out, and Syt1/Doc2a/Doc2b TKO mice were prepared
as previously described (Groffen et al., 2010). Shortly, neurons were
plated at 50,000 per well on a confluent layer of glia in 12-well plates. The
cells were infected with lentiviral vectors encoding GFP, Doc2b WT,
Doc2b C2AB, Doc2a WT, Syt1 WT, Syt1-Doc2b WT, or Syt1-Doc2b DN on
DIV2. For whole-cell recordings at DIV10 –17, the neurons were ana-
lyzed with the same internal and external media as in autapses, except
that the bath contained 1 M tetrodotoxin (TTX) to block Na  currents
(Ascent) and 20 M gabazine (GZ) to block GABAA receptor-mediated
currents (Sigma). The experimenters were blind to the expressed con-
structs during the recordings and analyses.
Immunocytochemistry. To verify the expression and localization of the
different constructs, mouse hippocampal neurons were cultured in net-
works at a density of 25,000/well and transduced at DIV2 with lentiviral
particles (3 l/well). At DIV14, the cells were fixed with 4% PFA and
permeabilized with 0.1% Triton X-100 in PBS for 5 min. Constructs
containing the N-terminal domain of Syt1 were stained with a mouse
monoclonal antibody raised against amino acids 1–12 of rat Syt1 (1:2000
in PBS supplemented with 10% normal goat serum; #105221, Synaptic
Systems). This antibody does not react with endogenous mouse Syt1.
Synapses were stained with rabbit polyclonal E028 against Synapsin 1/2
(1:1000; Hosaka and Südhof, 1999). All constructs containing the
N-terminal domain of Doc2a/Doc2b were stained with rabbit polyclonal
antibody (pAb) 13.2 (fraction 5, diluted 1:200), which was cross ab-
sorbed against Doc2a/Doc2b DKO mouse brain lysate to remove aspe-
cific activity (Groffen et al., 2010). A mouse monoclonal against
synaptobrevin-2 was used to identify synapses (1:2000, clone 69.1; Synaptic Sys-
tems). To stain the Doc2bC2AB construct, which lacks the immunogen used
to raise pAb 13.2, a mouse pAb anti-Doc2b (H00008447, Abnova) was
used at 1:200, combined with rabbit anti-Synapsin. After labeling by
secondary antibodies conjugated to Alexa 546 and Alexa 647, coverslips
were mounted in Mowiol 4 – 88 (Aldrich) and images were acquired on
an A1R confocal laser microscope (Nikon) controlled by NIS-elements
AR version 4.30 (Laboratory Imaging).
Experimental design and statistical analysis. Neurons were cultured
from E18-stage embryos without sex determination, thus using both
male and female mice. In experiments aimed at testing the effect of overex-
pressed proteins, untransfected cells from the same culture batch were used
as an internal control. This is important to minimize confounding effects
caused by weekly experimental variations: each week uses a different culture
batch from a different mouse embryo, which is reflected by weekly variations
in the average mEPSC frequency of the untransfected control cells. Details of
all statistical tests are listed in Table 1.
Results
To investigate whether Doc2 proteins underlie the high rate of
spontaneous release in Syt1-deficient neurons, we generated
TKO mice lacking Syt1 (Geppert et al., 1994), Doc2a (Sakagu-
chi et al., 1999), and Doc2b (Groffen et al., 2010). TKO mice
showed a similar severe phenotype as Syt1-null mice, charac-
terized by normal embryonic development and death imme-
diately following birth, associated with a lack of movement
and respiration.
Doc2a/Doc2b are not responsible for the high spontaneous
release rate in Syt1-deficient neurons
TKO hippocampal neurons were cultured either on glial microis-
lands to induce self-innervation (autapses; Fig. 2A–E) or in net-
work cultures (Fig. 2F–H). As expected due to the absence of Syt1
(Geppert et al., 1994), TKO neurons showed no synchronous
neurotransmission upon induction of a single action potential
(Fig. 2D,E). In a direct comparison between neurons lacking Syt1
alone (SKO; Syt1/) or lacking all three sensors (TKO; Syt1/,
Doc2a/, Doc2b/), the peak EPSC amplitude in TKO neu-
rons was slightly higher than that of SKO neurons (1.1  0.22 and
0.47  0.06 nA, respectively; p  0.0322, Kruskal–Wallis and
Dunn’s test; Fig. 2E, left). The deletion of Doc2 proteins did not
reduce the asynchronous charge (SKO, 30  4.4 pC; TKO, 63 
13 pC; SKO  Syt1 neurons, 44  15 pC; p  0.0922, Kruskal–
Wallis and Dunn’s tests; Fig. 2E, right). Expression of Syt1 in SKO
neurons caused much higher EPSC amplitudes (3.4  0.9 nA;
p  0.000063, Kruskal–Wallis and Dunn’s tests). The mean spon-
taneous release frequency was not significantly reduced in the
absence of Doc2 proteins (Fig. 2B). In previous studies, autap-
tic and continental Syt1-deficient neurons were shown to have
different spontaneous release phenotypes (Liu et al., 2009).
Therefore, we also used network cultures and recorded spon-
taneous mEPSC events in the presence of tetrodotoxin (TTX)
and gabazine (GZ). Again, the genetic ablation of Doc2 pro-
teins did not reduce the mini frequency (Fig. 2 F, G). In both
islands and networks, the expression of Syt1 in SKO neurons
reduced the mEPSC frequency to normal levels, as expected
(Fig. 2 B, G; p  0.019 and p  0.000035, respectively, Dunn’s
tests). These results confirm earlier observations in an shRNA-
based study (Pang et al., 2011), together indicating that the
high mini frequency in Syt1 knock-out neurons is not attrib-
utable to Doc2a/Doc2b. Unexpectedly, we observed a decrease
in the mEPSC 10 –90% rise time upon expression of Syt1 in
null neurons in networks ( p  0.01), but this observation was
not made in autapses.
Expression and subcellular distribution of
recombinant proteins
In view of the similar SNARE-binding and phospholipid-binding
activities of Syt1 and Doc2, we also investigated the effect of Doc2
overexpression on spontaneous release. In addition to wild-type
Syt1, Doc2a, and Doc2b, we designed mutated and hybrid
variants of these proteins (see Fig. 1 for an overview). To test
the expression and localization of these constructs, neurons
expressing them were stained with antibodies against Doc2
and synaptic markers (Fig. 3). Most Doc2 constructs were
homogeneously distributed throughout the soma and neurite
extensions. In addition, Doc2b DN was found at the plasma
membrane. Despite the lack of a synaptic targeting signal,
immunoreactivity was also detectable in synapses (Fig. 3, ar-
rowheads). Likewise, all constructs containing the N-terminal
domain of Syt1 were readily detectable by immunocytochem-
istry. As predicted by the trafficking signals in the N-terminal
domain (Kang et al., 2004), and consistent with previous ex-
periments (Xue et al., 2015), these constructs were effectively
targeted to synapses (Fig. 4).
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Doc2b overexpression inhibits spontaneous release in
TKO neurons
Interestingly, Doc2b overexpression caused a twofold reduction
of the mEPSC frequency in TKO islands (from 100% in untrans-
fected cells to 46  5% in Doc2b WT-expressing cells; p 
0.000006, Kruskal–Wallis and Dunn’s tests; Fig. 2K,L, compare
green and black). The data are also provided in Table 1. A similar
reduction was observed in Doc2b-overexpressing networks
(to 50  5% of controls; p  0.000001, Kruskal–Wallis and
Dunn’s tests; Fig. 2 I, J, green versus black). This inhibitory
effect was specific for Doc2b (Fig. 2J ), even though Doc2a was
present in synapses (Fig. 3). Although Dunn’s test reported a
different data distribution for Doc2a ( p  0.015), the mean
mEPSC frequency was identical to that of untransfected neu-
rons, so we conclude that Doc2a did not inhibit spontaneous
release. The inhibitory effect of Doc2b was accompanied by a
slightly reduced asynchronous release component, but this
effect was not significant (Fig. 2 M, N, right, green versus
black). Synchronous release remained absent (Fig. 2 M, N,
green versus black). Thus, in TKO neurons, overexpression of
Doc2b inhibits spontaneous release.
Spontaneous release inhibition by Doc2b depends on its
Munc13-interacting domain
In wild-type neurons, Doc2b overexpression did not inhibit























































































































































































































































































































































































27 1258 27 1258
Figure 2. Doc2 proteins are not responsible for the high frequency of spontaneous release in SKO neurons, and the MID is necessary for an inhibitory role of Doc2b overexpressed in TKO
neurons. A–C, Representative traces (A), average frequency (B), and amplitude (C) of spontaneous mEPSCs recorded from autaptic cultures of SKO, TKO, or SKO neurons overexpressing
Syt1. D, E, Representative traces (D) and average peak amplitude (E, left) and asynchronous charge (E, right) of evoked EPSCs recorded from autaptic neurons with the same genotypes.
F–H, Representative traces (F ), average frequency (G), and amplitude (H ) of spontaneous mEPSCs recorded from network cultures of SKO, TKO, or SKO neurons overexpressing Syt1. TTX
(1 M) and GZ (20 M) were added to the extracellular solution to prevent network activity and isolate excitatory events. I,J, Representative traces (I ) and average frequency (J ) of
spontaneous mEPSCs recorded from network cultures of TKO neurons overexpressing Doc2b, Doc2a, Doc2b C2AB, or Syt1 in the presence of 1 M TTX and 20 M GZ. K, L, Representative
traces (K ) and average frequency (L) of spontaneous mEPSCs recorded from autaptic cultures of TKO neurons overexpressing Doc2b, Doc2b MID, Doc2b DN, or Syt1. M, N, Repre-
sentative traces recorded from TKO neurons overexpressing Doc2b or Doc2b DN (M ) and average peak amplitude (N, left) and asynchronous charge (N, right) of evoked EPSCs. J, L, N,
Values of cells expressing various constructs were normalized to the mean value of untransfected cells. Error bars indicate SEs. Cell numbers are indicated within bars. *p  0.05, ***p 
0.001.
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We hypothesized that Doc2, which is sol-
uble in the cytoplasm, cannot compete ef-
ficiently with Syt1, which is anchored to
the vesicle membrane of wild-type cells.
In addition to Ca 2, Munc13 can also tar-
get Doc2b to the plasma membrane by its
N-terminal MID (Orita et al., 1997; Dun-
can et al., 1999; Friedrich et al., 2013;
Houy et al., 2017). To test whether
Doc2b-mediated inhibition of spontane-
ous release requires Munc13 binding, the
N-terminal domain was either deleted
or mutated. Upon deletion of the
N-terminal domain, the C2AB fragment
of Doc2b (Doc2b C2AB) lost its inhibitory
effect on spontaneous release (Fig. 2J).
Likewise, when the Munc13 interaction
was blocked by a previously characterized
mutation at amino acids 15–20 (Orita et
al., 1997; Mochida et al., 1998; Groffen et
al., 2004), full-length Doc2b lost its ability
to inhibit spontaneous release (Fig. 2L,
Doc2b MID). The subcellular distribution
of the Doc2b MID mutant was not discern-
ible from Doc2b WT, including immuno-
reactivity in synapses (Fig. 3). Thus,
Munc13 interaction is not required for
synaptic delivery of Doc2b. Instead, the
mutation may affect the distribution of
Doc2 or Munc13 within synaptic mi-
crodomains, or alter the functional activ-
ity of either protein. Finally, a mutation
that mimics the effect of Ca 2 binding to
the C2A domain (Groffen et al., 2004;
Friedrich et al., 2008) did not inhibit
spontaneous release (Fig. 2L, Doc2b DN).
The asynchronous release component was
not reduced by overexpression of this mu-
tant either (Fig. 2N, right). Consistent
with other studies, Doc2b DN was enriched
at the plasma membrane of transfected
neurons (Groffen et al., 2006; Xue et al.,
2015; Houy et al., 2017; Bourgeois-
Jaarsma et al., 2019). Together, we con-
clude that the inhibitory activity of Doc2b in TKO cells requires
its Munc13 binding activity and is lost after neutralization of the
Ca 2-binding aspartates D218 and D220 in the C2A domain.
Doc2b overexpression in SKO neurons
Similar to the aforementioned experiments in TKO cells, full-
length Doc2a and Doc2b were also expressed in SKO neurons
lacking only Syt1. As previously reported (Geppert et al., 1994),
SKO autapses showed extremely small EPSC amplitudes (Fig.
5D,E), which were effectively rescued upon reintroduction of
Syt1 (the amplitude increased 10-fold after Syt1 expression in
SKO neurons, gray versus orange; p  0.0008, Kruskal–Wallis
and Dunn’s tests). Overexpression of Doc2b failed to rescue the
EPSC amplitude, which was almost identical to that of SKO
neurons (gray versus yellow). Overexpression of Doc2b re-
duced the mini frequency in SKO networks to 65  10% (Fig.
5 F, G; p  0.0387, Kruskal–Wallis and Dunn’s tests), but
this effect was not observed in autapses, where Doc2b-
overexpressing cells had a mini frequency of 90  20% relative
to untransfected controls (Fig. 5 A, B, gray versus yellow; p 
0.7289, Kruskal–Wallis and Dunn’s tests). Doc2a overexpres-
sion did not affect the spontaneous release frequency (Fig.
5F ), although an increase in mEPSC amplitude was observed
(Fig. 5H; p  0.0475, Kruskal–Wallis and Dunn’s tests). Fi-
nally, as expected, overexpression of wild-type Syt1 readily
decreased the mini frequency in both networks (to 30  8% of
controls; Fig. 5F; p  0.0016, Kruskal–Wallis and Dunn’s
tests) and autaptic neurons (to 22  7% of controls; Fig. 5B;
p  0.0027, Kruskal–Wallis and Dunn’s tests). Together, the
results suggest that Doc2b does not support secretion at Syt1-
dependent release sites: neither during the synchronous phase
(measured as EPSCs) nor during rest (mEPSCs).
The Syt1 N-terminal domain is essential for spontaneous
release inhibition
Previous studies suggested that the transmembrane domain






















Figure 3. Overexpressed Doc2 constructs are widely distributed in mouse hippocampal neurons with detectable expres-
sion in synapses (arrowheads). Doc2a WT, Doc2b WT, Doc2b MID, Doc2b DN, or Doc2B C2AB was coexpressed with EGFP from an
internal ribosomal entry site. Doc2a/Doc2b immunoreactivity was stained with rabbit polyclonal 13.2 combined with
mouse-anti-synaptobrevin as a synaptic marker. Alternatively, Doc2b C2AB, which lacks the 13.2 epitope, was stained with
mouse-anti-Doc2b (Abnova) combined with rabbit anti-synapsin-1/2 as the synaptic marker. Most Doc2 constructs are
homogeneously distributed in the soma and neurites of transfected neurons, except Doc2b DN, which was enriched on the
plasma membrane. When available, mouse neurons were derived from Doc2a/Doc2b DKO mice (Doc2b WT, Doc2b MID), but
in some cases (other constructs) wild-type cells were used. Arrowheads indicate selected synapses to illustrate that Doc2
immunoreactivity is also detectable in synapses.
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tens et al., 2007; Hui et al., 2009; Wang et al., 2011), although
it may contribute to vesicle docking (de Wit et al., 2009) and
recycling (Yao et al., 2011b). Interestingly, overexpression of
the C2AB fragment of Syt1 (Syt1 C2AB) in autaptic neurons had
no significant effect on the spontaneous release rate (80 
10% of control; Fig. 5B; p  0.9999, Kruskal–Wallis and
Dunn’s tests). Thus, the TMD is essential for spontaneous
release inhibition by Syt1.
The C2AB fragment of Syt1 synchronizes fusion during
sustained activity
Overexpression of Syt1 C2AB in Syt1-null neurons had a minor
effect on the EPSC amplitude (1.7-fold increase in SKO 
Syt1 C2AB; Fig. 5E; p  0.1640, Kruskal–Wallis and Dunn’s test).
During trains of 100 action potentials at 5 Hz, 50% of the neurons
overexpressing Syt1 C2AB showed a remarkable facilitation of the
EPSC amplitude, increasing from 0.8  0.2 nA (first AP) to 2.5 
0.4 nA (10th AP; Fig. 5I–K; p  0.000244, Wilcoxon matched-
pairs signed rank test), thereby reaching similar amplitudes as
SKO neurons overexpressing full-length Syt1 (increasing from
2.7  0.6 nA after the first AP to 3.1  0.4 nA after the 10th AP;
p  0.9860, Kruskal–Wallis and Dunn’s test). A small increase
was observed in Syt1-null neurons (first pulse, 0.66  0.18 nA;
10th pulse, 0.9  0.18 nA; Fig. 5J, left; p  0.021545, Wilcoxon
matched-pairs signed rank test); however, the amplitude of Syt1-
null neurons did not reach similar levels as Syt1-null neurons
overexpressing full-length Syt1 (p  0.0006, Kruskal–Wallis and
Dunn’s test). The effect of Syt1 C2AB was accompanied by a reduc-
tion of the 10 –90% rise time of the EPSCs that matched the
10 –90% rise time of the 10th pulse of Syt1-null neurons overex-
pressing full-length Syt1 (SKO  Syt1 C2AB, first pulse: 9.12 
3.12 ms, 10th pulse: 2.43  0.16 ms; SKO  Syt1 WT, first pulse:
2.14  0.21 ms, 10th pulse: 2.62  0.3 ms; Fig. 5J, right; p 
0.390805, Kruskal–Wallis and Dunn’s test). In contrast, SKO neu-
rons did not show a reduction of the 10 –90% EPSC rise time
upon synaptic activity (first pulse, 20.9 
2.6 ms; 10th pulse, 21.2  3.54 ms; p 
0.9999, Wilcoxon matched-pairs signed
rank test), indicating that the release re-
mained asynchronous. We conclude that
overexpression of the C2AB fragment of
Syt1 is sufficient for driving synchronous
release in a subset of neurons, and that this
effect depends on synaptic activity.
Intrinsic differences in fusion enhancement
by Doc2bC2AB and Syt1C2AB
Given the high degree of biochemical
similarity between the Syt1 C2AB and
Doc2b C2AB fragment, we next investi-
gated whether a hybrid construct, com-
posed of the N-terminal domain of Syt1
and the C2AB domain of Doc2b, substi-
tutes for wild-type Syt1 in synchronous
neurotransmitter release. In hippocampal
autapses, the high spontaneous release
rates of Syt1-null neurons remained high
after expression of the hybrid construct,
and the mEPSC rise time was reduced
compared with that of Syt1-null neurons
(Fig. 6A,B; p  0.01, Kruskal–Wallis and
Dunn’s test). A 1.7-fold increase in
mEPSC frequency was observed in cells
expressing the Syt1-Doc2B DN hybrid (p  0.01054, Kruskal–
Wallis and Dunn’s test). Moreover, an increase in the mEPSC
amplitude was observed in this group (p  0.0035, Kruskal–
Wallis and Dunn’s test). Synchronous neurotransmission was
not rescued by the Syt1-Doc2b hybrid, nor by the mutant variant
Syt1-Doc2B DN (Fig. 6D,E), even though the hybrid constructs
were targeted to synapses (Fig. 4). In network cultures, Syt1-
Doc2b DN expression did not significantly change the mEPSC
frequency and amplitude (Fig. 6G; p  0.2614 and 0.7487, respec-
tively, Kruskal–Wallis and Dunn’s test). Together, we conclude
that the C2AB domains of Syt1 and Doc2b are not functionally
interchangeable.
Discussion
Previous studies reported a strong increase in the frequency of
spontaneous neurotransmitter release events in neurons lacking
Syt1 (Littleton et al., 1993; Broadie et al., 1994; Xu et al., 2009). To
explain this phenomenon, it has been hypothesized that Doc2
proteins occupy vacant Syt1-dependent release sites, increasing
their apparent Ca 2 sensitivity and thereby causing a higher re-
lease probability at low resting Ca 2 concentrations (Walter et
al., 2011). Here, we tested this hypothesis by triple homologous
gene targeting of Syt1, Doc2a, and Doc2b in mouse neurons. We
conclude that the high spontaneous release rate in Syt1 cells does
not require Doc2a/Doc2b activity. This finding is consistent
with earlier knock-down experiments (Pang et al., 2011). Our
data show that the functional differences between Doc2b and
Syt1 are not limited to their different N-terminal domains but
are also encoded in the C2AB domain. In particular, the C2AB
domain of Doc2b cannot functionally replace that of Syt1, as
demonstrated by the inability of hybrid Syt1-Doc2b to
support synchronous fusion. In a previous study where pre-
synaptic neurons were locally stimulated in a network config-
uration, similar Syt1-Doc2b chimers also did not support



















Figure 4. Overexpressed Syt1 and Syt1-Doc2b are targeted to synapses. Rat Syt1 WT, Syt1-Doc2b WT, or Syt1-Doc2b DN was
expressed in wild-type mouse hippocampal neurons. EGFP was expressed as a separate protein from an internal ribosomal entry
site. After fixing at DIV14, the cells were stained with a monoclonal antibody specific for amino acids 1–12 of rat Syt1. This antibody
does not react with mouse Syt1. Synapsin-1/2 was stained to mark synapses. Many synapses express recombinant Syt1; a few
examples are highlighted by arrowheads.
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also demonstrated that the C2B domain of Doc2b exhibits
slower kinetics than Syt1. Thus, differences in both the kinet-
ics and affinity of Ca 2 and phospholipid binding likely con-
tribute to the divergent C2AB domain activity.
It is conceivable that different sensors have evolved to mediate
specialized Ca 2-secretion coupling processes in different sub-
cellular compartments. Moreover, different types of neurons
may bear different sets of presynaptic proteins to regulate vesicle
release. In line with this, a recent study has shown that Doc2a
and Doc2b are differentially expressed in the brain, facilitating
glutamatergic and GABAergic spontaneous release, respectively
(Courtney et al., 2018). Upon overexpression, however, Doc2b
restored the spontaneous release frequency in Doc2a-deficient
glutamatergic cells and vice versa, suggesting functional redun-
dancy (Courtney et al., 2018). Interestingly, our data now indi-
cate a functional difference between Doc2a and Doc2b: Doc2b
inhibited the spontaneous release rate, whereas Doc2a did not.
This observation was made in both TKO and SKO networks
(Figs. 2 I, J, 5F,G).
The inhibitory effect of Doc2b was evident in SKO network
cultures, but not autapses. As a key difference, networks are
mixed cultures that contain GABAergic cells. The long-term
spontaneous release of GABA can regulate mEPSC frequencies of
glutamatergic cells in a mixed culture (Wierda and Sørensen,
2014). In several studies, this effect has presumably masked the
high mEPSC frequency of Syt1-deficient neurons (Liu et al.,
2009; Wierda and Sørensen, 2014). In a similar manner, it is
possible that the inhibitory effect of Doc2b is an indirect conse-
quence of increased spontaneous GABA release. Because we in-
cluded gabazine to block GABAA receptors, this effect would have
to be mediated by metabotropic GABAB receptors. Interestingly,
mixed culture effects may also help explain why experiments in
locally stimulated networks suggest a role for Doc2b in asynchro-
nous release (Yao et al., 2011a), whereas autapse experiments do
not (Groffen et al., 2010).
At physiological extracellular Ca 2 concentrations ([Ca 2]0),
both Syt1 and Doc2b are required for driving spontaneous release


































































































































SKO SKO + Syt1C2AB SKO + Syt1
I J























































































































































0.5 nA 1 s
5 Hz train of 100 APs 
7
G HF
Figure 5. The transmembrane domain of Syt1 is necessary for its inhibitory role on mEPSCs in hippocampal neurons. To control for variation between independent experiments, mEPSC
frequencies and amplitudes were normalized to the mean value of untransfected neurons measured in the same experiment. A–C, Representative traces (A), average frequency (B), and amplitude
(C) of spontaneous mEPSCs recorded from Syt1 SKO neurons in autaptic culture, untransfected or overexpressing Doc2b, Syt1 C2AB, or Syt1. D, E, Representative traces (D) and average peak amplitude
(E) of evoked EPSCs recorded from autaptic SKO neurons, untransfected or overexpressing Doc2b, Syt1 C2AB, or Syt1. F–H, Representative traces (F ), average frequency (G), and amplitude (H ) of
spontaneous mEPSCs recorded from network cultures of SKO neurons, untransfected or overexpressing Doc2b, Doc2a, or Syt1. To prevent network activity and isolate excitatory events, TTX (1 M)
and GZ (20 M) were added to the extracellular solution. I, Representative traces of the first and the 10th evoked EPSCs from a train of 100 APs elicited at 5 Hz, recorded from autaptic SKO neurons,
untransfected or overexpressing Syt1 C2AB or Syt1. J, Average peak amplitude (left) and 10 –90% rise time (right) of the first and 10th evoked EPSC from the train (n  15 untransfected, 13
Syt1 C2AB-expressing and 7 Syt1-expressing cells). K, Representative traces showing the full EPSC recording throughout the 5 Hz train. Error bars indicate SEs. Cell numbers are indicated within bars.
*p  0.05, **p  0.01, ***p  0.001.
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minis in glutamatergic neurons, an action that depended on
Doc2a alone (Courtney et al., 2018). Thus, it is possible that the
promoting role of Syt1 on spontaneous release described by Xu et
al. (2009) is restricted to higher [Ca 2]0. Our results support a
multisensor model where specialized Ca 2 sensors act together
to determine the Ca 2-dependent synaptic release rate, each con-
tributing to a distinct kinetic component of the overall release in
hippocampal synapses. This model is compatible with the previ-
ously described two-sensor model (Goda and Stevens, 1994),
which already noted that the “second sensor” could represent a
collection of molecules. We suggest that at least three classes of
sensors underlie synaptic secretion. The first class of sensors
(Syt1, Syt2, or Syt9) promotes fast membrane fusion during ac-
tion potential-evoked Ca 2 transients but does not support se-
cretory events at resting Ca 2, at least not in excitatory neurons
(Courtney et al., 2018). A second class of sensors is responsible for
the “asynchronous” release of neurotransmitters evoked by ac-
tion potentials. Syt7 was shown to belong to this class (Bacaj et al.,
2013; Luo and Südhof, 2017); however, it is not responsible for
increased spontaneous release in Syt1-deficient neurons. A third
class, including Doc2b, does not support synchronous fusion but
promotes secretory events in the absence of action potentials.
Doc2 proteins have also been proposed to play a role in asynchro-
nous release (Yao et al., 2011a), although this finding was not
reproducible in our hands, possibly due to different experimental
conditions. A recent study also showed a novel role for Doc2
proteins as part of the Ca 2 sensor machinery that drives
augmentation (Xue et al., 2018). Finally, the mechanism of spon-
taneous release in TKO neurons remains to be identified. It is
possible that this class comprises a fourth class of Ca 2-sensing
molecules, but alternatively, sensorless fusion may occur. The
likelihood of spontaneous release events is regulated by extracel-
lular Ca 2 concentrations (Xu et al., 2009; Smith et al., 2012), the
stochastic opening of voltage-dependent channels (Ermolyuk et
al., 2013), or intracellular Ca 2 channels (Llano et al., 2000;
Emptage et al., 2001).
In wild-type neurons, Doc2b positively contributes to spon-
taneous release (Groffen et al., 2010), and its overexpression does
not inhibit the mini frequency, suggesting that endogenous
Doc2b is not rate limiting. Overexpression of Doc2b in the ab-
sence of Syt1, however, revealed a negative contribution to spon-
taneous release. The inhibitory activity of Doc2b required an
intact N-terminal domain and was blocked by mutations in the
Munc13-interacting domain. In chromaffin cells, Doc2b also has
mixed positive and inhibitory effects on regulated secretion, both
of which are dependent on the MID domain (Houy et al., 2017).
The domain likely contributes to local enrichment of Doc2b at
release sites, even though the Doc2b MID mutant is expressed in
synaptic structures. The MID domains of Doc2a and Doc2b
are highly conserved, and both isoforms bind to Munc13
(Orita et al., 1997; Duncan et al., 1999). Local accumulation
also appears to be relevant for Syt1-dependent inhibition of
spontaneous release, because this activity is abolished by de-
letion of the transmembrane domain. Thus, in general, Ca 2
sensors may inhibit spontaneous release by binding to release
sites under conditions in which the C2AB domain is not acti-
vated. These conditions may include low intracellular Ca 2
concentrations, sensor protein mistargeting, or mutations
that block fusogenic activity. In line with this model, minimal
fragments comprising the C2AB domain of Syt1 and Doc2b
are sufficient to drive membrane fusion in reconstituted
SNARE liposomes (Martens et al., 2007; Hui et al., 2009; Grof-
fen et al., 2010; Wang et al., 2011). The C2AB fragment of
Doc2b has also been shown to interact with opposing membranes,
directly participating in Ca2-dependent and phosphatidylserine-
dependent stalk formation and hemifusion in a SNARE-free assay
(Brouwer et al., 2015).
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Figure 6. The C2AB domain of Doc2b is not capable of replacing that of Syt1 in synchronous
neurotransmitter secretion. To control for variation between independent experiments, mEPSC
frequencies and amplitudes were normalized to the mean value of untransfected neurons mea-
sured in the same experiment. A–C, Representative traces (A), average frequency (B), and
amplitude (C) of spontaneous mEPSCs recorded from autaptic cultures of SKO neurons overex-
pressing Syt1-Doc2b WT or Syt1-Doc2b DN. D, E, Representative traces (D) and average peak
amplitude (E) of evoked EPSCs recorded from autaptic SKO neurons overexpressing Syt1-
Doc2b WT or Syt1-Doc2b DN. F–H, Representative traces (F ), average frequency (G), and ampli-
tude (H ) of spontaneous mEPSCs recorded from network hippocampal cultures of SKO
overexpressing Syt1-Doc2b WT or Syt1-Doc2b DN. TTX (1 M) and GZ (20 M) were added to the
extracellular solution to prevent network activity and isolate excitatory events. Error bars indi-
cate SE. Cell numbers are indicated in bar graphs. *p  0.05, **p  0.01.
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Table 1. Summary of data and statistical analyses
Parameter df Test/H df Test/H df Test/H df Test/H
Figure 2
Genotype autaptic cells (n) mEPSC frequency (Hz) Kruskal–Wallis mEPSC amplitude (pA) Kruskal–Wallis mEPSC rise time (ms) Kruskal–Wallis mEPSC decay time (ms) Kruskal–Wallis
SKO (control; 69) 15.7  1.6 17.3  0.5 1.8  0.05 2.8  0.1
TKO (44) 15.2  1.7
( p  0.9999)
2 7.032 16.5  0.8
( p  0.3836)
2 1.920 1.9  0.1 ( p  0.9999) 2 7.750 3  0.1 ( p  0.3654) 2 3.017
SKO  Syt1 (7) 4.8  1.9*
( p  0.0190)
2 7.032 18.1  2.4
( p  0.9999)
2 1.920 1.4  0.2 ( p  0.0232) 2 7.750 2.6  0.4 ( p  0.8000) 2 3.017
Genotype continental cells (n) mEPSC frequency (Hz) Kruskal–Wallis mEPSC amplitude (pA) Kruskal–Wallis mEPSC rise time (ms) Kruskal–Wallis mEPSC decay time (ms) Kruskal–Wallis
SKO (control; 87) 8.8  0.8 15  0.6 1.9  0.1 2.8  0.1
TKO (66) 8.4  0.7
( p  0.9584)
2 21.48 15.4  0.7
( p  0.2187)
2 3.150 1.7  0.1 ( p  0.3322) 8.457 2.7  0.1 ( p  0.9999) 2 3.742
SKO  Syt (12) 2.8  0.7***
( p  0.000035)
2 21.48 19.2  2.1
( p  0.5328)
2 3.150 1.6  0.1* ( p  0.0100) 8.457 2.5  0.2 ( p  0.1061). 2 3.742
Genotype autaptic cells (n) EPSC size (pA) Kruskal–Wallis EPSC async. charge (pC) Kruskal–Wallis
SKO (control; 25) 466.1  64.3 30  4
TKO (22) 1128  222.6*
( p  0.0322)
2 18.22 63  13
( p  0.0922)
2 4.053
SKO  Syt1 (10) 3376  887***
( p  0.000063)
2 18.22 44  15
( p  0.9999)
2 4.053




Kruskal–Wallis Normalized mEPSC rise time Kruskal–Wallis Normalized mEPSC decay
time
Kruskal–Wallis
TKO (control) (63) 1  0.1 1  0.03 1  0.03 1  0.03
TKO  Doc2b (40) 0.46  0.07***
( p  0.000006)
3 28.41 0.8  0.03
( p  0.167)
3 8.527 1  0.05 ( p  0.9999) 3 2.485 1  0.05 ( p  0.9999) 3 1.875
TKO  Doc2bMID (9) 0.9  0.1
( p  0.9999)
3 28.41 0.9  0.1
( p  0.4114)
3 8.527 0.9  0.06 ( p  0.9999) 3 2.485 0.9  0.1 ( p  0.7457) 3 1.875
TKO  Doc2bDN (9) 1.1  0.2
( p  0.9999)
3 28.41 0.9  0.05
( p  0.9999)
3 8.527 1.2  0.2 ( p  0.5603) 3 2.485 1.1  0.1 ( p  0.9999) 3 1.875
Genotype continental cells (n) Normalized mEPSC
frequency
Kruskal–Wallis
TKO (control; 82) 1  0.07
TKO  Doc2b (77) 0.5  0.06***
( p  0.000001)
4 44.96
TKO  Doc2a (31) 1  0.3*
( p  0.0153)
4 44.96
TKO  Doc2bC2AB (17) 1.8  0.4
( p  0.9818)
4 44.96
TKO  Syt1 (27) 0.6  0.06
( p  0.1566)
4 44.96





TKO (control; 58) 1  0.1 1  0.16
TKO  Doc2b (27) 0.6  0.1
( p  0.1462)
2 3.3323 0.65  0.13
( p  0.0684)
2 4.487
TKO  Doc2bDN (12) 0.8  0.1( p0.9999) 2 3.3323 0.7  0.15( p0.9999) 2 4.487
Figure 5




Kruskal–Wallis Normalized mEPSC rise time Kruskal–Wallis Normalized mEPSC decay
time
Kruskal–Wallis
SKO (control; 58) 1  0.1 1  0.03 1  0.03 1  0.02
SKO  Doc2b (26) 0.9  0.2( p0.7289) 3 11.35 1  0.07( p0.9999) 3 3.788 0.9  0.05 ( p  0.2735) 3 3.776 0.9  0.04 ( p  0.9999) 3 4.020
SKO  SytC2AB (26) 0.8  0.1( p0.9999) 3 11.35 0.9  0.05( p0.1824) 3 3.788 0.9  0.04 ( p  0,9999) 3 3.776 0.9  0.14 ( p  0.1564) 3 4.020
SKO  Syt1 (7) 0.22  0.07**
( p  0,0027)
3 11.35 0.9  0.12
( p  0.9999)
3 3.788 0.9  0.13 ( p  0.6479) 3 3.776 0.9  0.05 ( p  0.9999) 3 4.020




Kruskal–Wallis Normalized mEPSC rise time Kruskal–Wallis Normalized mEPSC decay
time
Kruskal–Wallis
SKO (control; 20) 1  0.13 1  0.04 1  0.05 1  0.06
SKO  Doc2b (33) 0.65  0.1*
( p  0.0387)
3 15.21 1.1  0.06
( p  0.9999)
3 8.058 1.13  0.05 ( p  0.4392) 3 14.09 1.13  0.06 ( p  0.5737) 3 4.866
SKO  Doc2a (6) 0.1  0.2 ( p  0.9999) 3 15.21 1.3  0.08*
( p  0.0475)
3 8.058 0.8  0.06 ( p  0.5051) 3 14.09 0.97  0.08 ( p  0.9999) 3 4.866
SKO  Syt1 (12) 0.3  0.08**
( p  0.0016)
3 15.21 1.3  0.13
( p  0.1388)
3 8.058 0.7  0.06 ( p  0.1324) 3 14.09 0.9  0.14 (0.9999) 3 4.866
Genotype autaptic cells (n) Normalized EPSC size Kruskal–Wallis
SKO (control; 53) 1  0.11
SKO  Doc2b (21) 1.1  0.22
( p  0.9999)
3 15.57
SKO  SytC2AB (26) 1.74  0.35
( p  0.1640)
3 15.57
SKO  Syt1 (10) 10.8  5.7***
( p  0.0008)
3 15.57
Genotype autaptic cells (n) EPSC size first pulse (pA) Kruskal–Wallis EPSC size 10th pulse (pA) Kruskal–Wallis EPSC size first versus 10th (paired
measurements)
SKO (control) (15) 628.2  180.7 909.3  183 SKO* ( p  0.021545) Wilcoxon matched-pairs signed rank test a
SKO  SytC2AB (13) 790.2  237.3
( p  0.9999)
2 11.79 2490.4  373.4**
( p  0.0032)
2 16.69 SKO  SytC2AB***
( p  0.000244)
Wilcoxon matched-pairs signed rank test a
(Table continues)
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In most cases, the overexpressed constructs did not alter the
mEPSC amplitude, which is primarily determined by postsyn-
aptic processes. However, in SKO neurons expressing Doc2a,
Syt1, or Syt1-Doc2b DN, a small but significant increase of the
mEPSC amplitude was observed. In another study, Doc2a ex-
pressed in wild-type neurons did not affect the mEPSC ampli-
tude (Yao et al., 2011a). Syt1 expressed in SKO neurons also
did not affect it (Tagliatti et al., 2020). Consistent with our
data, mEPSC amplitude was unchanged by Syt1-Doc2 WT ex-
pressed in SKO neurons (Xue et al., 2015). Overall, we are
reluctant to draw strong conclusions from the small effects on
mEPSC amplitude.
Previous work also indicated that the C2AB domain of Syt1 is
sufficient for eliciting synchronous release when targeted to the
plasma membrane using GAP-43 (Yao et al., 2011b). In this
work, we show that the soluble C2AB fragment of Syt1 is capable
of driving synchronous release in a subset of Syt1-null neurons,
and that this action appears to depend on synaptic activity and
concurrent Ca 2 accumulation at the synaptic terminal. Recent
work has characterized a role for Syt1 in tethering synaptic vesi-
cles close to the active zone at rest (Chang et al., 2018). This action
does not involve its Ca 2-binding regions but requires the poly-
basic side (K324 –K327) and bottom residues (R398, R399) of the
C2B domain, as well as an (at least partially) assembled SNARE
complex. Upon AP induction and Ca 2 entry, the authors ob-
served an increase in synaptic vesicle density at the active zone,
an effect that depended on Ca 2 sensing by Syt1. We hypoth-
esize that local accumulation of the soluble C2AB fragment of
Syt1 at the active zone by a classical C2 activation mechanism
could explain the partial rescue of synchronous release. The
levels of soluble C2AB fragments present at the active zone are
likely to vary among synapses, giving rise to differences in the
extent to which synchronous release is restored. In line with
the aforementioned study, we observed a progressive increase
in EPSC size as well as resynchronization of release upon syn-
aptic activity, consistent with a Ca 2-dependent action of the
C2AB fragment in rapidly recruiting synaptic vesicles to the
active zone and catalyzing fast release by bringing the synaptic
vesicle membrane and plasma membrane closer together.
Thus, we conclude that the transmembrane domain is crucial
for reliable triggering of synchronous release, whereas the
C2AB fragment of Syt1 alone requires membrane enrichment
to carry out its Ca 2-dependent docking and bridging actions
that trigger synchronous release.
In summary, we conclude that, despite their similarity, the
C2AB fragments of Doc2b and Syt1 have divergent functions in
driving spontaneous and synchronous neurotransmitter release,
and that the high quantal release frequency in Syt1-null neurons
relies on mechanisms independent of Doc2a/Doc2b.
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Table 1. Continued
Parameter df Test/H df Test/H df Test/H df Test/H
SKO  Syt1 (7) 2707  610**
( p  0.0022)
2 11.79 3098  449.4***
(vs control)
( p  0.0006);
n.s. (vs SKO 
SytC2AB)
( p  0.9860)
2 16.69 SKO  Syt ( p  0.2188) Wilcoxon matched-pairs signed rank test a
Genotype autaptic cells (n) EPSC first pulse 10 –90%
rise time (ms)
Kruskal–Wallis EPSC 10th pulse 10 –90%
rise time (ms)
Kruskal–Wallis Rise time first vs 10th pulse
(paired measurements)
SKO (control) (15) 21.2  2.2 23  3.8 SKO ( p  0.9999) Wilcoxon matched-pairs signed rank test a
SKO  SytC2AB (13) 9.1  3.1**
( p  0.00483)
2 23.65 2.4  0.2***
( p  0.000002)
2 31.17 SKO  SytC2AB ( p  0.108154) Wilcoxon matched-pairs signed rank test a
SKO  Syt1 (7) 2.1  0.2*** vs control
( p  0.000011); n.s.
vs SKO  SytC2AB
( p  0.390805)
2 23.65 2.6  0.3*** vs control
( p  0.000026); n.s.
vs SKO  SytC2AB
( p  0.999999)
2 31.17 SKO  Syt1* ( p  0.0420) Wilcoxon matched-pairs signed rank test a
Figure 6




Kruskal–Wallis Normalized mEPSC rise time Kruskal–Wallis Normalized mEPSC decay
time
Kruskal–Wallis
SKO (control; 27) 1  0.16 1  0.04 1  0.03 1  0.04
SKO  Syt1-Doc2bWT (24) 1.2  0.17
( p  0.5254)
2 7.790 1.1  0.05
( p  0.4791)
2 9.855 0.8  0.04** ( p  0.01) 2 12.99 0.8  0.04 ( p  0.1115) 2 10.86
SKO  Syt1-Doc2bDN (17) 1.7  0.2*
( p  0.01054)
2 7.790 1.2  0.06**
( p  0.0035)
2 9.855 1.1  0.05 ( p  0.7952) 2 12.99 1.1  0.05 ( p  0.2139) 2 10.86




Kruskal–Wallis Normalized mEPSC rise time Kruskal–Wallis Normalized mEPSC decay
time
Kruskal–Wallis
SKO (control; 20) 1  0.17 1  0.08 1  0.08 1  0.07
SKO  Syt1-Doc2bWT (30) 1.4  0.2 ( p  0.4809) 2 2.415 1  0.1 ( p  0.9999) 2 0.7947 1.18  0.07 ( p  0.2751) 5.509 1.2  0.1 ( p  0.1080) 3.782
SKO  Syt1-Doc2bDN (26) 1.5  0.2 ( p  0.2614) 2 2.415 0.9  0.1 ( p  0.7487) 2 0.7947 1.24  0.07 ( p  0.0383) 5.509 1.1  0.05 ( p  0.3633) 3.782
Genotype autaptic cells (n) Normalized EPSC size Kruskal–Wallis
SKO (control) (19) 1  0.25
SKO  Syt1-Doc2bWT (16) 0.5  0.07
( p  0.3221)
2 9.055
SKO  Syt1-Doc2bDN (15) 1.5  0.34
( p  0.1758)
2 9.055
Values of p correspond to Dunn’s adjusted p values, except for paired tests where the Wilcoxon matched-pairs signed rank test was applied. *p  0.05, **p  0.01, ***p  0.001, n.s., not significant.
aWilcoxon matched-pairs signed rank test was applied.
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